Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2006. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2615333014 | Amlodipine maleate (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 2617998014 | Amlodipine maleate | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 791131000172113 | maléate d'amlodipine | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | Belgian module (core metadata concept) |
| 791141000172118 | amlodipinemaleaat | nl | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | Belgian module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Amlodipine maleate (substance) | Is a | Amlodipine (substance) | false | Inferred relationship | Some | ||
| Amlodipine maleate (substance) | Has disposition (attribute) | Calcium channel blocker (disposition) | true | Inferred relationship | Some | ||
| Amlodipine maleate (substance) | Is a | Dihydropyridine derivative calcium channel blocker | true | Inferred relationship | Some | ||
| Amlodipine maleate (substance) | Is modification of (attribute) | Amlodipine (substance) | true | Inferred relationship | Some | ||
| Amlodipine maleate (substance) | Is a | Hypotensive agent (substance) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely amlodipine (as amlodipine maleate) 5 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | True | Amlodipine maleate (substance) | Inferred relationship | Some | 1 |
Reference Sets
Belgian subset for AllergyIntolerance, causative agent, drug
FHIR